4 March 2024
AstraZeneca PLC 04 March 2024 4 March 2024 Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung…
4 March 2024 Aviva to enter Lloyd’s market via acquisition of Probitas • Entry into Lloyd’s market via acquisition of a high quality, fully-integrated…
29 February 2024
GSK plc (LSE/NYSE: GSK) today confirmed it has reached a confidential settlement with Boyd/Steenvoord, resolving the case filed in California state court. The case,…
29 February 2024 RUFFER INVESTMENT COMPANY LIMITED (a closed-ended investment company incorporated in Guernsey with registration number 41996) (the “Company“) Half-Yearly Financial Report The…
29 February 2024 London Stock Exchange Group plc Directorate Change London Stock Exchange Group plc (“LSEG”) today announces that Ashok Vaswani will step down…
Continued strong performance: accelerating growth, significant strategic progress, substantial returns to shareholders David Schwimmer, CEO said: “2023 was another strong year for LSEG. We…
28 February 2024
28 February 2024 The Renewables Infrastructure Group Limited“TRIG” or “the Company”, a London-listed investment company advised by InfraRed Capital Partners (“InfraRed”) as Investment Manager…
A YEAR OF PROGRESS WITH MID-SINGLE-DIGIT GROWTH IN HEALTH & HYGIENE Adjusted1 IFRS Unaudited £m 2023 vs 20222 Unaudited £m 2023 vs 20222 Full…